Dual STAT‑3 and IL‑6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL‑6/IL‑6R/STAT‑3 axis-Reference-Cited by-同舟云学术

Dual STAT‑3 and IL‑6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL‑6/IL‑6R/STAT‑3 axis

Published:2022-06-14 Issue:2 Volume:48 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Méndez‑Clemente Anibal¹,Bravo‑Cuellar Alejandro²,González‑Ochoa Salvador¹,Santiago‑Mercado Maria²,Palafox‑Mariscal Luis¹,Jave‑Suárez Luis¹,Solorzano‑Ibarra Fabiola³,Villaseñor‑García Maria²,Ortiz‑Lazareno Pablo²,Hernández‑Flores Georgina²

Affiliation:

1. Doctoral Program in Biomedical Sciences Orientation Immunology, University Center for Health Sciences (CUCS), University of Guadalajara (UdeG), Guadalajara, Jalisco 44340, México

2. Immunology Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, Jalisco 44340, México

3. Chronic Degenerative Diseases Research Institute Postdoctoral Stays Program for Mexico 2021, Department of Molecular and Genomic Biology, University of Guadalajara (UdeG), University Center for Health Sciences (CUCS), Guadalajara, Jalisco 44340, México

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Reference75 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. IL-6 in inflammation, autoimmunity and cancer;Hirano;Int Immunol,2021

3. Chronic inflammation and cytokines in the tumor microenvironment;Landskron;J Immunol Res,2014

4. Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer;Michalaki;Br J Cancer,2004

5. IL-6 and ovarian cancer: Inflammatory cytokines in promotion of metastasis;Browning;Cancer Manag Res,2018

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the contribution of tumor-associated macrophages in driving epithelial-mesenchymal transition: a review of mechanisms and therapeutic Strategies;Frontiers in Pharmacology;2024-09-02

2. Cellular senescence in metastatic prostate cancer: A therapeutic opportunity or challenge (Review);Molecular Medicine Reports;2024-07-08

3. The “Heater” of “Cold” Tumors–Blocking IL‐6;Advanced Biology;2024-05-22

4. Effect of anti-COVID-19 drugs on patients with cancer;European Journal of Medicinal Chemistry;2024-03

5. IDO1 Inhibition Promotes Activation of Tumor-intrinsic STAT3 Pathway and Induces Adverse Tumor-protective Effects;The Journal of Immunology;2024-02-23